RxDoctor Payments Data

Rosanna Lapham, MD

Anatomic Pathology & Clinical Pathology · Spartanburg, SCNPI 1255306809

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,974 of the $6,428 with a category attached, or 92.9%. 9 manufacturers reported payments, led by Eli Lilly at 38.5% of the total. Reporting peaked in 2021 at $2,702 and has fallen 96.1% since, to $105 in 2025. Among anatomic pathology & clinical pathology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,428in general payments, 2019–2025

Across 22 payments — averaging $292.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • AstraZeneca$2K
  • Bayer$2K
  • Genentech USA, Inc.$122
  • Merck$103
  • Roche Diagnostics Corporation$47
  • plus $79 from 3 others

What the payments were for

  • Consulting fees$5,97493%
  • Food & beverage$4547%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,428 in reported general payments places this provider in the 95th percentile of 129 anatomic pathology & clinical pathology providers in South Carolina.

See all anatomic pathology & clinical pathology providers in South Carolina

Medicare billing

Part B allowed, 2024
$115,336
Medicare patients
1,116
Services billed
2,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →